Bladder sarcoma treated with radical cystectomy and adjuvant epirubicin and ifosfamide chemotherapy: a case report - Takeaways - MDSpire

Bladder sarcoma treated with radical cystectomy and adjuvant epirubicin and ifosfamide chemotherapy: a case report

  • By

  • Jiaxin Liu

  • Hui Han

  • Shuangping Lu

  • Siming Chen

  • Yuchen Jiang

  • Zhu Wang

  • Xuebing Han

  • May 12, 2026

  • 0 min

Share

  • 1

    Bladder sarcoma is a rare tumor, comprising approximately 0.3% of bladder tumors, complicating preoperative diagnosis due to nonspecific symptoms.

  • 2

    A 53-year-old male patient with painless gross hematuria was diagnosed with a small round cell undifferentiated sarcoma after radical cystectomy.

  • 3

    The patient underwent laparoscopic radical cystectomy with pelvic lymph node dissection and received six cycles of adjuvant chemotherapy with epirubicin and ifosfamide.

  • 4

    At the 12-month follow-up, the patient showed no evidence of tumor recurrence or distant metastasis, indicating short-term efficacy of the treatment.

  • 5

    This case highlights the need for further research on standardized treatment protocols for bladder sarcoma due to its rarity and aggressive nature.

Original Source(s)

Bladder sarcoma treated with radical cystectomy and adjuvant epirubicin and ifosfamide chemotherapy: a case report

  • by Jiaxin Liu, Hui Han, Shuangping Lu, Siming Chen, Yuchen Jiang, Zhu Wang, Xuebing Han

  • May 12, 2026

Related Content

Retraction: MicroRNA-935 directly targets FZD6 to inhibit the proliferation of human glioblastoma and correlate to glioma malignancy and prognosis

  • May 28, 2026

VANGL1 links angiogenesis–stemness programs and tumor microenvironment remodeling: a pan-cancer, multi-omics study with translational validation

FEBAIR microsurgical principles in meningiomas and recurrence: a long-term follow-up series